Related Experiment Video

Updated: May 18, 2026

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic

Davood Bashash1, Seyed H Ghaffari, Rooholah Mirzaee

  • 1Department of Hematology, Faculty of Allied Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Leukemia & Lymphoma
|September 11, 2012
PubMed

Insights

The non-nucleoside telomerase inhibitor BIBR1532 induces rapid cell death in pre-B acute lymphoblastic leukemia (ALL) cells. This occurs through suppressing survivin, c-Myc, and human telomerase reverse transcriptase (hTERT) expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Unlimited proliferative potential is a key cancer hallmark.
  • Telomere maintenance is crucial for cancer cell survival.
  • Targeting telomerase offers a potential anticancer strategy.

Purpose of the Study:

  • To investigate the effects of BIBR1532, a non-nucleoside telomerase inhibitor, on pre-B acute lymphoblastic leukemia (ALL) cells.
  • To elucidate the molecular mechanisms underlying BIBR1532's action in ALL cells.

Main Methods:

  • Treatment of Nalm-6 cells (pre-B ALL cell line) with varying concentrations of BIBR1532.
  • Analysis of gene and protein expression, including survivin, c-Myc, and human telomerase reverse transcriptase (hTERT).
  • Assessment of apoptosis-related markers such as p73, Bax, Bcl-2, and caspase-3 activation.

Main Results:

  • BIBR1532 induced rapid cell death in Nalm-6 cells in a concentration-dependent manner.
  • The drug suppressed the expression of survivin, c-Myc, and hTERT.
  • High doses of BIBR1532 also triggered apoptosis through p73 induction, altered Bax/Bcl-2 ratio, and caspase-3 activation, independent of telomere erosion.

Conclusions:

  • BIBR1532 demonstrates potent cytotoxic effects against pre-B ALL cells.
  • The compound acts via multiple mechanisms, including suppression of key survival proteins and direct induction of apoptosis.
  • BIBR1532 represents a promising therapeutic agent for acute lymphoblastic leukemia.

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.